| Literature DB >> 27410162 |
Karina S S Vasconcelos1, João M D Dias1, Marília C Araújo1, Ana C Pinheiro1, Bruno S Moreira1, Rosângela C Dias1.
Abstract
BACKGROUND: Sarcopenic obesity is associated with disability in older people, especially in women. Resistance exercises are recommended for this population, but their efficacy is not clear.Entities:
Mesh:
Year: 2016 PMID: 27410162 PMCID: PMC5123261 DOI: 10.1590/bjpt-rbf.2014.0174
Source DB: PubMed Journal: Braz J Phys Ther ISSN: 1413-3555 Impact factor: 3.377
Figure 1Design and flow of participants in the study.
Description and progression of exercise program.
|
|
| |||
|---|---|---|---|---|
| Weeks 1 to 10 | Stretching exercises - 1 set of 60 s, resting time of 60 s between each exercise | |||
| Open chain | Closed chain | |||
| In supine position: | In standing position: | |||
| Period and loading | Resistance exercises – resting time of 30 s between sets and 60 s between exercises | |||
| Weeks 1 to 2 | Open chain | Closed chain | ||
| • 2 x 12 (50% of 1RM) for knee exercises | In supine position: | In prone position: | In upright position: | |
| Weeks 3 to 4 | ||||
| • 2 x 12 (75% of 1RM) for knee
exercises | ||||
| Weeks 5 to 6 | Open chain | Closed chain | ||
| • 2 x 12 (40% of new 1RM) for knee
exercises | In supine position: | In upright position: | ||
|
| ||||
| • 2 x 12 (60% of new 1RM) for knee
exercises | ||||
|
| ||||
| • 3 x 12 (60% of new 1RM) for knee
exercises | ||||
Baseline characteristics of participants (n=28).
|
|
|
|
|---|---|---|
|
| 72±4.6 | 72±3.6 |
|
| 6.8±3.6 | 6.5±3.8 |
|
| 73±6.5 | 76±6.7 |
|
| 1.5±0.04 | 1.5±0.05 |
|
| 32±2.3 | 33±2.9 |
|
| 104±8.2 | 103±6.7 |
|
| 5.6±1.9 | 4.4±1.8 |
|
| 4.0±1.8 | 5.9±3.2 |
|
| ||
|
| 11 (78) | 9 (64) |
|
| 3 (21) | 2 (14) |
Mean±SD of pre- and post-treatment outcomes of exercise and control groups, mean±SD of within-group differences, and mean (95%CI) of between-group differences for primary and secondary outcomes.
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
|
| 103.38±7.13 | 105.74±6.63 | 104.47±6.74 | 95.77±8.25 | 2.36±12.0 | -8.70±20.0 | -6 (-0.90 to 12) |
|
| 87.55±5.25 | 103.42±6.84 | 89.31±5.88 | 91.38±7.15 | 15.87±13.8 | 2.07±23.8 | 13 (-1.4 to 28) |
|
| 21.16±3.83 | 27.56±2.94 | 24.65±3.06 | 23.69±3.46 | 6.4±20.0 | -0.96±9.0 | 7.6 (-4.5 to 24) |
|
| 11.00±1.4 | 11.40±1.0 | 10.00±1.1 | 10.57±1.2 | 0.40±1.3 | 0.57±1.0 | -0.14 (-1.04 to 0.76) |
|
| 1.09±0.10 | 1.11±0.16 | 1.04±0.19 | 1.09±0.11 | 0.02±0.01 | 0.05±0.17 | 0.09 (0.07 to -0.15) |
|
| 81±21 | 80±23 | 72±23 | 78±22 | -1.0±12.4 | 6.0±13.7 | -7 (-11 to 3) |
PRE: Pre-treatment; POST: Post-treatment; SPPB: Short Physical Performance Battery.
P-value<0.05.